Clinical Trial Update: Microbial Resistance of Rifaximin in Hepatic Encephalopathy [Phase 4]

View source ↗

Summary

Phase 4 trial update on rifaximin for hepatic encephalopathy focusing on microbial resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: National Hepatology & Tropical Medicine Research Institute | Conditions: Hepatic Encephalopathy | Phase 4 | Status: COMPLETED